Possible Regulation of Migration of Intrahepatic Cholangiocarcinoma Cells by Interaction of CXCR4 Expressed in Carcinoma Cells with Tumor Necrosis Factor-alpha and Stromal-derived Factor-1 Released in Stroma

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2006 Mar 28

PMID 16565491

Citations 55

Authors

Shusaku Ohira

Motoko Sasaki

Kenichi Harada

Yasunori Sato

Yoh Zen

Kumiko Isse

Kazuto Kozaka

Akira Ishikawa

Koji Oda

Yuji Nimura

Yasuni Nakanuma

Affiliations

Soon will be listed here.

Abstract

Intrahepatic cholangiocarcinoma (ICC) is highly fatal because of early invasion, widespread metastasis, and lack of an effective therapy. We examined roles of CXCR4 and its ligand, stromal cell-derived factor (SDF)-1, in migration of ICC with respect to tumor-stromal interaction by using two ICC cell lines, a fibroblast cell line (WI-38), and 28 human ICC tissues. The two ICC cell lines expressed CXCR4 mRNA and protein, and WI-38 fibroblasts expressed SDF-1 mRNA and protein. Migration of cultured ICC cells in Matrigel was induced by co-culture with WI-38 fibroblasts and by incubation with SDF-1. Anti-SDF-1 antibody suppressed migration, demonstrating that SDF-1 released from WI-38 fibroblasts was responsible for this migration. Tumor necrosis factor (TNF)-alpha pretreatment of ICC cells up-regulated CXCR4 mRNA and protein expression in a concentration-dependent manner. Administration of SDF-1 and TNF-alpha increased synergistically ICC cell migration, which was suppressed by the CXCR4 antagonist AMD3100. In ICC tissue, TNF-alpha was mainly expressed in infiltrated macrophages, CXCR4 in ICC cells, and SDF-1 in stromal fibroblasts. In conclusion, the interaction of SDF-1 released from fibroblasts and CXCR4 expressed on ICC cells may be actively involved in ICC migration, and TNF-alpha may enhance ICC cell migration by increasing CXCR4 expression. CXCR4 could be a therapeutic target to prevent ICC invasion.

Citing Articles

Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.

Mussa A, Ismail N, Hamid M, Al-Hatamleh M, Bragoli A, Hajissa K J Exp Clin Cancer Res. 2024; 43(1):312.

PMID: 39609700 PMC: 11603874. DOI: 10.1186/s13046-024-03218-1.

Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review).

Yang S, Zou R, Dai Y, Hu Y, Li F, Hu H Int J Oncol. 2023; 63(6).

PMID: 37888583 PMC: 10631767. DOI: 10.3892/ijo.2023.5585.

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).

Yang R, Song Y, Shakoor K, Yi W, Peng C, Liu S Mol Med Rep. 2022; 25(5).

PMID: 35302174 PMC: 8971913. DOI: 10.3892/mmr.2022.12687.

Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer.

Kato T, Matsuo Y, Ueda G, Murase H, Aoyama Y, Omi K Oncol Rep. 2022; 47(4).

PMID: 35119076 PMC: 8848476. DOI: 10.3892/or.2022.8279.

The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma.

Huang W, Yeh C Biomolecules. 2020; 10(10).

PMID: 33007962 PMC: 7600158. DOI: 10.3390/biom10101396.

References

Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y . Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest. 2003; 83(11):1657-67. DOI: 10.1097/01.lab.0000097190.56734.fe. View

Wang J, Deng X, Gong W, Su S . Chemokines and their role in tumor growth and metastasis. J Immunol Methods. 1998; 220(1-2):1-17. DOI: 10.1016/s0022-1759(98)00128-8. View

Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G . Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer. 1997; 74(3):335-45. DOI: 10.1002/(sici)1097-0215(19970620)74:3<335::aid-ijc18>3.0.co;2-a. View

Charnaux N, Brule S, Hamon M, Chaigneau T, Saffar L, Prost C . Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12. FEBS J. 2005; 272(8):1937-51. DOI: 10.1111/j.1742-4658.2005.04624.x. View

Harada K, Masuda S, Hirano M, Nakanuma Y . Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma. Hum Pathol. 2003; 34(9):857-63. DOI: 10.1016/s0046-8177(03)00336-8. View

Katerinaki E, Evans G, Lorigan P, MacNeil S . TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer. 2003; 89(6):1123-9. PMC: 2376936. DOI: 10.1038/sj.bjc.6601257. View

Kamihira T, Shimoda S, Harada K, Kawano A, Handa M, Baba E . Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology. 2003; 125(5):1379-87. DOI: 10.1016/j.gastro.2003.07.013. View

Yamashiro M, Kouda W, Kono N, Tsuneyama K, Matsui O, Nakanuma Y . Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study. Virchows Arch. 1998; 433(5):471-9. DOI: 10.1007/s004280050276. View

Sugawara H, Yasoshima M, Katayanagi K, Kono N, Watanabe Y, Harada K . Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology. 1998; 33(2):145-53. DOI: 10.1046/j.1365-2559.1998.00445.x. View

10.

Schrader A, Lechner O, Templin M, Dittmar K, Machtens S, Mengel M . CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer. 2002; 86(8):1250-6. PMC: 2375348. DOI: 10.1038/sj.bjc.6600221. View

11.

Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S . Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res. 2000; 6(9):3530-5. View

12.

Rosen E, Goldberg I, Liu D, Setter E, Donovan M, Bhargava M . Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res. 1991; 51(19):5315-21. View

13.

Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk S, Farrugia D . Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res. 2004; 64(10):3517-24. DOI: 10.1158/0008-5472.CAN-03-2770. View

14.

Csiszar A, Szentes T, Haraszti B, Balazs A, Petranyi G, Pocsik E . The pattern of cytokine gene expression in human colorectal carcinoma. Pathol Oncol Res. 2004; 10(2):109-16. DOI: 10.1007/BF02893465. View

15.

Salvucci O, Basik M, Yao L, Bianchi R, Tosato G . Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J Leukoc Biol. 2004; 76(1):217-26. DOI: 10.1189/jlb.1203609. View

16.

Blackhall F, Merry C, Davies E, Jayson G . Heparan sulfate proteoglycans and cancer. Br J Cancer. 2001; 85(8):1094-8. PMC: 2375159. DOI: 10.1054/bjoc.2001.2054. View

17.

Sehgal A, Ricks S, Boynton A, Warrick J, Murphy G . Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J Surg Oncol. 1999; 69(4):239-48. DOI: 10.1002/(sici)1096-9098(199812)69:4<239::aid-jso9>3.0.co;2-u. View

18.

Michalaki V, Syrigos K, Charles P, Waxman J . Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004; 90(12):2312-6. PMC: 2409519. DOI: 10.1038/sj.bjc.6601814. View

19.

Zhou Y, Larsen P, Hao C, Yong V . CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002; 277(51):49481-7. DOI: 10.1074/jbc.M206222200. View

20.

Wu X, Jin C, Wang F, Yu C, McKeehan W . Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Cancer Res. 2003; 63(16):4936-44. View